← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2026-01-21

Drug application

FDA Application #

ANDA220268

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GLENMARK PHARMS

Manufacturer

GLENMARK PHARMACEUTICALS INC., USA

First approval

2026-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown